PMID- 22084943 OWN - NLM STAT- MEDLINE DCOM- 20120823 LR - 20120612 IS - 1537-2995 (Electronic) IS - 0041-1132 (Linking) VI - 52 IP - 6 DP - 2012 Jun TI - Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation. PG - 1321-32 LID - 10.1111/j.1537-2995.2011.03442.x [doi] AB - BACKGROUND: Recovery and survival of transfused platelets (PLTs) are usually assessed by radioisotope labeling methods for evaluation of transfusion efficacy and new progress in the processing of PLT concentrates. Alternative, nonradioactive methods are warranted. STUDY DESIGN AND METHODS: A multicolor flow cytometry method was developed for simultaneous studies of recovery, survival, and function of transfused PLTs. Eight consecutive patients undergoing allogeneic stem cell transplantation (TX) were transfused with apheresis PLTs of nonself human leukocyte antigen (HLA) Class I types, and HLA Class I discrepancy between donor and recipient was used to identify transfused PLTs. Hematologic status and HLA Class I surface expression were analyzed immediately before transfusion, 1 and 6 hours after transfusion, and daily during the subsequent week. PLT activation was assessed by surface expression of CD63, CD62P, or CD42a, before and after stimulation with thrombin receptor agonist peptide. RESULTS: PLT recovery was 43, 41, and 31% for fresh (5-72 hr old) and 30, 27, and 17% for stored (73-148 hr old) PLTs, after 1, 6, and 15 to 28 hours, respectively. Survival of fresh versus stored PLTs were 160 and 105 hours, respectively. Spontaneous PLT activation and residual activation potential were almost equal for fresh and stored PLTs. PLT engraftment was detected between Day 7 and Day 9, which was significantly earlier than first sign of neutrophil engraftment (Days 11-19; p=0.01). CONCLUSION: Flow cytometry is an attractive alternative to radiolabeling of PLTs for simultaneous studies of survival, recovery, and function of transfused PLTs and early detection of PLT engraftment after allogeneic stem cell TX. CI - (c) 2011 American Association of Blood Banks. FAU - Vetlesen, Annette AU - Vetlesen A AD - Department of Immunology and Transfusion Medicine, Oslo University Hospital HF, Ullevaal, Norway. annette.vetlesen@medisin.uio.no FAU - Holme, Pal Andre AU - Holme PA FAU - Lyberg, Torstein AU - Lyberg T FAU - Kjeldsen-Kragh, Jens AU - Kjeldsen-Kragh J LA - eng PT - Clinical Trial PT - Journal Article DEP - 20111116 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 SB - IM MH - Adult MH - Blood Platelets/*cytology/*physiology MH - Blood Specimen Collection/methods MH - Cell Survival/physiology MH - Female MH - Graft Survival/*physiology MH - *Hematopoietic Stem Cell Transplantation MH - Humans MH - Male MH - Middle Aged MH - Platelet Count MH - *Platelet Transfusion/methods MH - Plateletpheresis/methods MH - Recovery of Function/physiology MH - Time Factors MH - Transplantation, Homologous MH - Young Adult EDAT- 2011/11/17 06:00 MHDA- 2012/08/24 06:00 CRDT- 2011/11/17 06:00 PHST- 2011/11/17 06:00 [entrez] PHST- 2011/11/17 06:00 [pubmed] PHST- 2012/08/24 06:00 [medline] AID - 10.1111/j.1537-2995.2011.03442.x [doi] PST - ppublish SO - Transfusion. 2012 Jun;52(6):1321-32. doi: 10.1111/j.1537-2995.2011.03442.x. Epub 2011 Nov 16.